Skip to the page

Data / Drug companies / Rocuronium bromide

Rocuronium bromide: 25 companies and 67 products in the FDA NDC directory

Rocuronium bromide is listed in the FDA National Drug Code Directory by 25 companies, with 67 products in commercial distribution. 60 of the products (89.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection; solution, and the newest product started marketing on September 18, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
25
Products
67
Generic (ANDA) products
60 (89.6%)
Application numbers
17
Routes
Intravenous
Brand names
Rocuronium
openFDA record search
api.fda.gov

Companies that list rocuronium bromide

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
HF Acquisition Co LLC, DBA HealthFirst8injection, solution; injectionGeneric drugs (ANDA)July 17, 2023
Medical Purchasing Solutions, LLC8injection; injection, solutionGeneric drugs (ANDA)October 3, 2024
Hospira, Inc.6injection, solutionGeneric drugs (ANDA)August 28, 2023
Fresenius Kabi USA, LLC5injection, solutionNew drug applications (NDA)October 11, 2023
Baxter Healthcare Corporation4injection; injection, solutionGeneric drugs (ANDA)September 18, 2026
Meitheal Pharmaceuticals Inc.4injectionGeneric drugs (ANDA)May 8, 2023
ProPharma Distribution3injection, solution; injectionGeneric drugs (ANDA)October 3, 2024
Be Pharmaceuticals Inc.2injection, solutionGeneric drugs (ANDA)July 12, 2023
Caplin Steriles Limited2injection, solutionGeneric drugs (ANDA)October 3, 2024
Civica, Inc.2injectionGeneric drugs (ANDA)December 16, 2020
Eugia US LLC2injection, solutionGeneric drugs (ANDA)April 12, 2017
Fresenius Kabi USA, LLC2injection, solutionGeneric drugs (ANDA)December 13, 2009
Fresenius Kabi USA, LLC2injection, solutionNew drug applications (NDA)October 11, 2023
Gland Pharma Limited2injectionGeneric drugs (ANDA)May 18, 2018
Hikma Pharmaceuticals USA Inc.2injectionGeneric drugs (ANDA)April 30, 2017
Lifestar Pharma LLC2injectionGeneric drugs (ANDA)May 29, 2025
Shandong New Time Pharmaceutical Co., Ltd.2injection, solutionGeneric drugs (ANDA)July 12, 2024
Solco Healthcare US, LLC2injectionGeneric drugs (ANDA)July 25, 2021
B. Braun Medical Inc.1injectionNew drug applications (NDA)May 21, 2026
Mylan Institutional LLC1injectionGeneric drugs (ANDA)February 6, 2012
Phlow Corporation1injection, solutionGeneric drugs (ANDA)February 8, 2022
Sagent Pharmaceuticals1injectionGeneric drugs (ANDA)October 15, 2023
Sandoz Inc1injection, solutionGeneric drugs (ANDA)December 5, 2008
Steriscience Specialties Private Limited1injection, solutionGeneric drugs (ANDA)November 30, 2024
XGen Pharmaceuticals DJB, Inc.1solutionGeneric drugs (ANDA)December 1, 2012

Dosage forms

Dosage formProductsShare
Injection, solution3958.2%
Injection2537.3%
Solution34.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)6089.6%
New drug applications (NDA)710.4%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.